Skip to main content
Clinical Trials/JPRN-UMIN000020663
JPRN-UMIN000020663
Completed
未知

A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib. - A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib.

Kyusyu University Hospital Medicine and biosystemic science0 sites20 target enrollmentJanuary 21, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Kyusyu University Hospital Medicine and biosystemic science
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2016
End Date
December 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kyusyu University Hospital Medicine and biosystemic science

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.A patient with tuberculosis or non\-tuberculous mycobacteria. 2 .A patient who is positive for HBs antigen or HBV DNA not receiving nucleotide analogue. 3\. A patient who has an active infectious disease. 4\. A patient who has concurrent malignancy or its previous history. 5\. A patient with reduced renal function less than CLcr15/min. 6\. A patient with reduced hepatic function more than 10 points of Child\-Pugh score (grade C) 7\. A patient with interstitial pneumonia. 8\. A pregnant or breastfeeding women or a women who may be pregnant. 9\. A patient who has hypersensitivity reaction to ingredients in this drug. 10\. A patient who meets any of followings: less than 1000/mm3 peripheral neutrophils or less than 8g/dL hemoglobin. 11\. A patient who is regarded as inappropriate to participate in the study by a doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials